Dementia due to use of sedatives, hypnotics or anxiolytics (Q40244): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed label, description and/or aliases in pt-br, en |
||
| description / pt-br | description / pt-br | ||
Demência devida ao uso de sedativos, hipnóticos ou ansiolíticos é caracterizada pelo desenvolvimento de comprometimentos cognitivos persistentes (ex. problemas de memória, comprometimento da linguagem, e uma incapacidade de desempenhar tarefas motoras complexas) que preenchem os critérios diagnósticos para demência e são considerados consequência direta do uso de sedativos, hipnóticos, ou ansiolíticos e que persistem além da duração habitual da ação ou da síndrome de abstinência associada à substância. A quantidade e duração do uso de sedativos, hipnóticos, ou ansiolíticos devem ser suficientes para produzir o comprometimento cognitivo. O comprometimento cognitivo não é mais bem explicado por um transtorno que não seja induzido por sedativos, hipnóticos, ou ansiolíticos, tal como a demência devida a outra condição médica. | |||
| description / en | description / en | ||
Dementia due to use of sedatives, hypnotics or anxiolytics is characterised by the development of persistent cognitive impairments (e.g., memory problems, language impairment, and an inability to perform complex motor tasks) that meet the definitional requirements of Dementia that are judged to be a direct consequence of sedative, hypnotic, or anxiolytic use and that persist beyond the usual duration of action or withdrawal syndrome associated with the substance. The amount and duration of sedative, hypnotic, or anxiolytic use must be sufficient to produce the cognitive impairment. The cognitive impairment is not better accounted for by a disorder that is not induced by sedatives, hypnotics, or anxiolytics such as a dementia due to another medical condition. | |||
Revision as of 05:58, 13 August 2026
Dementia due to use of sedatives, hypnotics or anxiolytics is characterised by the development of persistent cognitive impairments (e.g., memory problems, language impairment, and an inability to perform complex motor tasks) that meet the definitional requirements of Dementia that are judged to be a direct consequence of sedative, hypnotic, or anxiolytic use and that persist beyond the usual duration of action or withdrawal syndrome associated with the substance. The amount and duration of sedative, hypnotic, or anxiolytic use must be sufficient to produce the cognitive impairment. The cognitive impairment is not better accounted for by a disorder that is not induced by sedatives, hypnotics, or anxiolytics such as a dementia due to another medical condition.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | 6D84.1 |
||
| English | Dementia due to use of sedatives, hypnotics or anxiolytics |
Dementia due to use of sedatives, hypnotics or anxiolytics is characterised by the development of persistent cognitive impairments (e.g., memory problems, language impairment, and an inability to perform complex motor tasks) that meet the definitional requirements of Dementia that are judged to be a direct consequence of sedative, hypnotic, or anxiolytic use and that persist beyond the usual duration of action or withdrawal syndrome associated with the substance. The amount and duration of sedative, hypnotic, or anxiolytic use must be sufficient to produce the cognitive impairment. The cognitive impairment is not better accounted for by a disorder that is not induced by sedatives, hypnotics, or anxiolytics such as a dementia due to another medical condition. |
